logo
Hepatitis C Virus and Nonliver Solid Organ Transplantation
Willingness to Pursue Live-Donor Kidney Transplantation Among Waitlisted Patients Infected With Human Immunodeficiency Virus (HIV)
Sorafenib Induces Autophagy in Human Myeloid Dendritic Cells and Prolongs Survival of Skin Allografts
Allogeneic Bone Marrow Cocultured With Human Islets Significantly Improves Islet Survival and Function In Vivo
Effect of Peripheral Vascular Disease on Kidney Allograft Outcomes
Acute But Transient Release of Terminal Complement Complex After Reperfusion in Clinical Kidney Transplantation
CYP3A5 Gene Variation Influences Cyclosporine A Metabolite Formation and Renal Cyclosporine Disposition
CYP3A and ABCB1 Genetic Polymorphisms on the Pharmacokinetics and Pharmacodynamics of Tacrolimus and Its Metabolites (M-I and M-III)
miRNA Profiling Discriminates Types of Rejection and Injury in Human Renal Allografts
Monitoring for HHV-6 Infection After Renal Transplantation
Study of the Ophthalmic System of Babies Delivered to Transplant Recipients
Efficacy, Outcomes, and Cost-Effectiveness of Desensitization Using IVIG and Rituximab
Combined Heart and Liver Transplant Attenuates Cardiac Allograft Vasculopathy Compared with Isolated Heart Transplantation
Early Major Neurologic Complications After Lung Transplantation
Hepatic Hemangiosarcoma
Surgical Site Infections After Kidney Transplantation—Where Do We Stand Now?
Living-Donor Follow-Up Attitudes and Practices in U.S. Kidney and Liver Donor Programs
Effects of ACE Inhibitors on Long-Term Outcome of Renal Transplant Recipients
Donor and Recipient BKV-Specific IgG Antibody and Posttransplantation BKV Infection
Defining the Benefits of Desensitization Therapy
Reply to “Defining the Benefits of Desensitization Therapy”
Reply to “Defining the Benefits of Desensitization Therapy”
Long-Term Renal Allograft Survival After Posttransplantation Diagnosis of Primary Hyperoxaluria
A Vast Amount of Enzyme Activity Fails to Be Absorbed Within the Human Pancreas
Impact of Conversion From Pegylated Interferon-α2b to Interferon-α2a for Treating Recurrent Hepatitis C After Liver Transplantation
Anonymity and Live-Donor Transplantation
Research Highlights and Editors’ Picks